| Xaverce vs Law | 23–12 | 65.71% |
| Xaverce vs King | 21–10 | 67.74% |
| Xaverce vs Jun | 14–14 | 50.00% |
| Xaverce vs Hwoarang | 12–13 | 48.00% |
| Xaverce vs Steve | 21–4 | 84.00% |
| Xaverce vs Yoshimitsu | 12–12 | 50.00% |
| Xaverce vs Jin | 11–13 | 45.83% |
| Xaverce vs Armor King | 16–8 | 66.67% |
| Xaverce vs Kazuya | 14–8 | 63.64% |
| Xaverce vs Bryan | 15–5 | 75.00% |
| Xaverce vs Xiaoyu | 10–8 | 55.56% |
| Xaverce vs Devil Jin | 8–10 | 44.44% |
| Xaverce vs Lee | 7–10 | 41.18% |
| Xaverce vs Eddy | 7–10 | 41.18% |
| Xaverce vs Anna | 8–8 | 50.00% |
| Xaverce vs Reina | 8–7 | 53.33% |
| Xaverce vs Lili | 11–3 | 78.57% |
| Xaverce vs Paul | 9–4 | 69.23% |
| Xaverce vs Leo | 4–8 | 33.33% |
| Xaverce vs Nina | 5–7 | 41.67% |
| Xaverce vs Leroy | 5–7 | 41.67% |
| Xaverce vs Asuka | 10–1 | 90.91% |
| Xaverce vs Lars | 7–4 | 63.64% |
| Xaverce vs Azucena | 6–5 | 54.55% |
| Xaverce vs Alisa | 5–5 | 50.00% |
| Xaverce vs Lidia | 4–6 | 40.00% |
| Xaverce vs Clive | 6–4 | 60.00% |
| Xaverce vs Feng | 3–6 | 33.33% |
| Xaverce vs Heihachi | 5–4 | 55.56% |
| Xaverce vs Victor | 2–6 | 25.00% |
| Xaverce vs Fahkumram | 3–2 | 60.00% |
| Xaverce vs Jack-8 | 2–2 | 50.00% |
| Xaverce vs Zafina | 2–2 | 50.00% |
| Xaverce vs Raven | 1–3 | 25.00% |
| Xaverce vs Dragunov | 0–2 | 0.00% |
| Xaverce vs Shaheen | 0–2 | 0.00% |
| Xaverce vs Kuma | 0–2 | 0.00% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.